Literature DB >> 17212987

Infectious keratitis following keratoplasty.

Rasik B Vajpayee1, Namrata Sharma, Rajesh Sinha, Tushar Agarwal, Arun Singhvi.   

Abstract

Infectious keratitis following corneal transplantation is one of the leading causes of failure of a corneal graft. The incidence of graft infection is variable, with developing countries having a higher incidence. The majority of the graft infections occur within 1 year of the corneal transplantation. Suture-related problems and persistent epithelial defect are the most common risk factors predisposing to graft infection. Pneumococcus species and Staphylococcus aureus have been found to be the commonest microorganisms in the developed world, whereas Staphylococcus epidermidis is the most often detected microorganism in corneal graft infection in the developing world. The early identification of predisposing risk factors in patients and their appropriate management at the earliest may prevent the occurrence of graft infection and might improve graft survival. Visual prognosis in eyes with post-keratoplasty graft infection is poor even after optimal therapy and there is a high rate of graft decompensation.

Entities:  

Mesh:

Year:  2007        PMID: 17212987     DOI: 10.1016/j.survophthal.2006.10.001

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  24 in total

1.  A case of acute postoperative keratitis after deep anterior lamellar keratoplasty by multidrug resistant Klebsiella.

Authors:  Leena Bajracharya; Binita Sharma; Reeta Gurung
Journal:  Indian J Ophthalmol       Date:  2015-04       Impact factor: 1.848

2.  Acute Klebsiella pneumoniae interface keratitis after deep anterior lamellar keratoplasty.

Authors:  Siamak Zarei-Ghanavati; Mohammad-Reza Sedaghat; Ali Ghavami-Shahri
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

3.  Long-term outcome and prognostic factor analysis for keratolimbal allografts.

Authors:  Eui Seok Han; Won Ryang Wee; Jin Hak Lee; Mee Kum Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-12       Impact factor: 3.117

4.  Severe donor-related Candida keratitis after Descemet's stripping automated endothelial keratoplasty.

Authors:  Katsuya Yamazoe; Seika Den; Takefumi Yamaguchi; Yoichi Tanaka; Jun Shimazaki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-05-17       Impact factor: 3.117

5.  Twelve-year follow-up of penetrating keratoplasty.

Authors:  Takashi Ono; Sosuke Ishiyama; Takeshi Hayashidera; Yosai Mori; Ryohei Nejima; Kazunori Miyata; Shiro Amano
Journal:  Jpn J Ophthalmol       Date:  2016-11-24       Impact factor: 2.447

6.  Role of neutrophils, MyD88-mediated neutrophil recruitment, and complement in antibody-mediated defense against Pseudomonas aeruginosa keratitis.

Authors:  Tanweer S Zaidi; Tauqeer Zaidi; Gerald B Pier
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-05       Impact factor: 4.799

7.  Microbial keratitis in corneal grafts: predisposing factors and outcomes.

Authors:  A C O Okonkwo; W F Siah; H D J Hogg; H Anwar; F C Figueiredo
Journal:  Eye (Lond)       Date:  2018-01-26       Impact factor: 3.775

8.  Microbiota-driven immune cellular maturation is essential for antibody-mediated adaptive immunity to Staphylococcus aureus infection in the eye.

Authors:  Tanweer Zaidi; Tauqeer Zaidi; Colette Cywes-Bentley; Roger Lu; Gregory P Priebe; Gerald B Pier
Journal:  Infect Immun       Date:  2014-06-09       Impact factor: 3.441

Review 9.  Post-keratoplasty Infectious Keratitis: Epidemiology, Risk Factors, Management, and Outcomes.

Authors:  Anna Song; Rashmi Deshmukh; Haotian Lin; Marcus Ang; Jodhbir S Mehta; James Chodosh; Dalia G Said; Harminder S Dua; Darren S J Ting
Journal:  Front Med (Lausanne)       Date:  2021-07-07

10.  Extracellular matrix protein lumican promotes clearance and resolution of Pseudomonas aeruginosa keratitis in a mouse model.

Authors:  Hanjuan Shao; Sherri-Gae Scott; Chiaki Nakata; Abdel R Hamad; Shukti Chakravarti
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.